PATIENT GUIDE. Highlights of Important Safety Information Warnings and Precautions. Your guide to treatment with Signifor LAR for acromegaly
|
|
- Philomena Marjory Singleton
- 5 years ago
- Views:
Transcription
1 PATIENT GUIDE Your guide to treatment with Signifor LAR for acromegaly Signifor LAR is indicated for the treatment of patients with acromegaly for whom surgery has not worked well enough or who cannot have surgery. Treatment with Signifor LAR may cause high blood sugar levels (hyperglycemia) and diabetes. Your health care provider should check your blood sugar level before you start receiving Signifor LAR and while you receive it. Tell your health care provider if you have any of these symptoms: excessive thirst urinate more than usual increased appetite with weight loss tiredness If you get hyperglycemia, your health care provider may give you medicine to lower your blood sugar. Your health care provider may also change your dose of Signifor LAR or ask you to stop receiving it.
2 Table of contents Before starting treatment Before starting treatment 3 How was Signifor LAR (pasireotide) for injectable suspension studied? 4 How will I receive treatment? 6 Resources and support 7 Possible serious side effects: high blood sugar 8 Other possible serious side effects 9 My treatment plan 10 Indication and Important Safety Information 11 Important things to remember 12 Treatment with Signifor LAR may cause your heart to beat slower (bradycardia) or cause changes in the electrical system of your heart (QT interval prolongation). Your health care provider should check your heart s electrical system with an ECG test prior to starting Signifor LAR and after 3 weeks in patients who may be at risk for electrical system problems. Call your health care provider right away if you experience any signs and symptoms such as: weakness dizziness fainting Beginning treatment with Signifor LAR (pasireotide) for injectable suspension is one step in what can be a long journey with this condition. The information in this brochure is intended to help you become familiar with Signifor LAR and how it works. What is Signifor LAR? Signifor LAR is a prescription medicine used to treat adults with acromegaly for whom surgery has not worked well enough or who cannot have surgery. What does my doctor need to know? 1 It s important to tell your doctor about your medical history before starting treatment with Signifor LAR. Please tell your health care provider if you: have high blood sugar (hyperglycemia) have diabetes have or have had heart problems, including an abnormal heart rate or rhythm or problems with the electrical system of your heart (QT prolongation) have a low level of potassium or magnesium in your blood have liver problems have gallstones (cholelithiasis) have any other medical conditions are pregnant or planning to become pregnant. Signifor LAR may harm your unborn baby. are breastfeeding or planning to breastfeed. It is not known if Signifor LAR passes into your breast milk. You and your health care provider should decide if you will receive Signifor LAR or breastfeed. You should not do both. Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Signifor LAR for injectable suspension is a type of medication called a somatostatin analog. 1 Somatostatin analogs work by suppressing secretion of growth hormone (GH), which can lead to decreases in insulin-like growth factor 1 (IGF-1). 1 Signifor LAR and other medicines may affect each other, causing side effects. Signifor LAR may affect the way other medicines work, and other medicines may affect how Signifor LAR works. Your health care provider may need to change your dose of Signifor LAR. Especially tell your health care provider if you take: medicines to control your heart beat (anti-arrhythmics) medicines to control your blood pressure (such as beta-blockers or calcium channel blockers) medicines to control the potassium and magnesium (electrolytes) levels in your body medicines that may affect the way the electrical system of your heart works (QT prolongation) cyclosporine bromocriptine Ask your health care provider for a list of these medicines if you are not sure. Know the medicines you take. Keep a list of them to show to your health care provider and pharmacist when you get a new medicine. 2 3
3 How was Signifor LAR (pasireotide) for injectable suspension studied? Study 1: Results of a study of people who either had at least 1 pituitary surgery or did not have pituitary surgery and who had never taken medication for acromegaly 1 How was Signifor LAR (pasireotide) for injectable suspension studied? (cont d) Study 2: Results of a study of people with acromegaly whose acromegaly was not controlled on another somatostatin analog 1 The people in this study showed a history of not responding to treatment with their current somatostatin analog. 31.3% had GH <2.5 µg/l and normalized IGF-1 after 12 months on Signifor LAR 98% vs of people with acromegaly on Signifor LAR had either a reduction in the volume of their pituitary tumor or no change during the study The median change in tumor volume was a reduction of 39.8% The change in tumor volume for these people ranged from a reduction of 97.6% to an increase of 16.9% 19.2% on another somatostatin analog. (The people in this group did not take the maximum dose of the somatostatin analog during the study.) All people in the same study taking either Signifor LAR or another somatostatin analog had smaller ring sizes, and other symptoms such as headache, fatigue, and perspiration were reduced 15.4% who took 40 mg of Signifor LAR every 4 weeks experienced a reduction in both GH and IGF-1 after 6 months 20% who took 60 mg of Signifor LAR every 4 weeks experienced a reduction in both GH and IGF-1 after 6 months vs vs 0% 0% 81% 70% of people with acromegaly who took 40 mg of Signifor LAR every 4 weeks had either a reduction in the volume of their pituitary tumor or no change during the study The median change in tumor volume was a reduction of 10.4% The change in tumor volume for these people ranged from a reduction of 74.5% to an increase of 19.4% who continued taking another somatostatin analog they had taken for at least 6 months before starting the study. (Approximately 75% of the people in this group did not take the maximum dose of the somatostatin analog they took during the study.) who continued taking another somatostatin analog they had taken for at least 6 months before starting the study. (Approximately 75% of the people in this group did not take the maximum dose of the somatostatin analog they took during the study.) of people with acromegaly who took 60 mg of Signifor LAR every 4 weeks had either a reduction in the volume of their pituitary tumor or no change during the study The median change in tumor volume was a reduction of 6.3% The change in tumor volume for these people ranged from a reduction of 66.7% to an increase of 14.5% Treatment with Signifor LAR may cause elevations in liver function tests; therefore, your health care provider may do blood tests to monitor your liver. Common Side Effects: Most patients experience side effects at some time. Some common side effects you may experience include: diarrhea, gallstones, high blood sugar, and diabetes mellitus. These are not all the possible side effects of Signifor LAR. Treatment with Signifor LAR may affect your gallbladder (gallstones, cholelithiasis). Tell your health care provider right away if you experience any of the following signs and symptoms: sudden pain in the upper right stomach area (abdomen) sudden pain in the right shoulder or between your shoulder blades yellowing of the skin and whites of your eyes fever and chills nausea 4 5
4 How will I receive treatment? Signifor LAR (pasireotide) for injectable suspension must be given by a trained health care provider as an injection into the muscle of your buttocks (intramuscularly). 1 Your health care provider will tell you how much Signifor LAR you will receive and when you will receive it. 1 Your health care provider may change your dose of Signifor LAR or the length of time between your injections. Your health care provider will tell you how long you need to receive Signifor LAR. 1 Before you receive Signifor LAR for the first time, your health care provider should do a blood test to check your fasting blood sugar level, electrolyte levels, and your liver function. 1 Before you receive Signifor LAR for the first time and during your treatment, your health care provider should do a test to check your heart (electrocardiogram). 1 How should I store Signifor LAR? 1 46 F 36 F Signifor LAR is administered once a month. Signifor LAR comes as an injection in 3 dosages (20 mg, 40 mg, and 60 mg), and can only be given to you by a trained health care provider. 1 Store Signifor LAR in the refrigerator between 36 F to 46 F (2 C to 8 C). Take Signifor LAR out of the refrigerator at least 30 minutes before you will receive it to allow it to come to room temperature. Do not use Signifor LAR if it has been out of the refrigerator and at room temperature for more than 24 hours. Your health care provider should give you Signifor LAR right away after it is mixed. Keep Signifor LAR and all medicines out of the reach of children. Treatment with Signifor LAR may affect your pituitary hormone levels (pituitary insufficiency). Signifor LAR may reduce the pituitary hormones in your body. Your health care provider should do a blood test to check your pituitary hormone levels before starting Signifor LAR and during treatment. Tell your health care provider if you experience any of these symptoms: nausea and vomiting tiredness dizziness diarrhea low blood glucose levels loss of appetite weight loss Resources and support A SHARED COMMITMENT TO ENHANCED PITUITARY CARE PEAK is an education and access program for patients with certain pituitary disorders. The PEAK program can help you: Access your medication Navigate the insurance process Connect with patient organizations and support groups PEAK aims to make it easier for you to find the support you need. TO LEARN MORE ABOUT PEAK The PEAK team can be reached Monday Friday (8 am 8 pm ET) to answer any questions or concerns you may have. How to contact PEAK: Online: By phone: Common Side Effects: Most patients experience side effects at some time. Some common side effects you may experience include: diarrhea, gallstones, high blood sugar, and diabetes mellitus. Tell your health care provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of Signifor LAR. For more information and to get advice about side effects, ask your health care provider or pharmacist. 6 7
5 Possible serious side effects: high blood sugar 1 Other possible serious side effects 1 High blood sugar (or hyperglycemia) and diabetes are possible serious side effects of treatment with Signifor LAR (pasireotide) for injectable suspension. One important part of managing side effects is making sure your blood sugar levels are regularly checked. When should my doctor check my blood sugar levels? Before you start treatment with Signifor LAR»»»»»»»»»»While you re receiving treatment with Signifor LAR If I do get hyperglycemia, how might my doctor help? Signs and symptoms of high blood sugar Tell your health care provider if you are: feeling very thirsty urinating more than usual hungrier than usual, with weight loss more tired than usual If you get hyperglycemia while receiving Signifor LAR, your health care provider may give you another medicine to lower your blood sugar. Your health care provider may also change your dose of Signifor LAR or advise you to stop receiving it. When it comes to side effects, each person may have a different experience. In addition to hyperglycemia, Signifor LAR (pasireotide) for injectable suspension may cause serious side effects, such as: slow heart rate (bradycardia). Signifor LAR can cause your heart to beat slower. People who have, or have had heart problems, or take certain medicines used to treat slow heart rate or that may cause a slow heart rate, are at higher risk for bradycardia. Tell your health care provider if you get any of these symptoms: weakness fainting or near fainting spells changes in the electrical system of your heart (QT interval prolongation). Tell your health care provider if you get any of these symptoms: weakness fainting or near fainting spells higher than normal liver function tests. Your health care provider should do blood tests to check your liver while you receive Signifor LAR. gallstones (cholelithiasis). Tell your health care provider if you get any of these symptoms: sudden pain in your upper right stomach area (abdomen) sudden pain in your right shoulder or between your shoulder blades yellowing of your skin and whites of your eyes fever with chills nausea low levels of pituitary hormones (pituitary insufficiency). Signifor LAR may reduce the pituitary hormones in your body. Your health care provider should do a blood test to check your pituitary hormone levels before you start receiving Signifor LAR and while you receive it. Tell your health care provider if you get any of these symptoms: nausea and vomiting tiredness diarrhea low blood glucose levels loss of appetite weight loss 8 9
6 My treatment plan Your doctor may use a treatment plan to help you stay on track with your therapy. The example plan below is for you and your doctor to fill out together. Your doctor may change your plan. Please bring the plan when you visit your doctor. The plan will help you remember some of the important parts of your treatment. My treatment goals My target growth hormone (GH) level is My target insulin-like growth factor 1 (IGF-1) level is Before I start treatment with Signifor LAR (pasireotide) for injectable suspension On / / my current GH level is On / / my current IGF-1 level is While I have treatment with Signifor LAR (After 3 months) On / / my GH level is (After 3 months) On / / my IGF-1 level is (After months) On / / my GH level is (After months) On / / my IGF-1 level is Other important things to talk to my doctor about What dose of Signifor LAR am I currently on? When will my dosage be reviewed? Has there been any change in my condition? Are there any lifestyle changes I should make? Before taking Signifor LAR: Tell your health care provider about all the medicines you take including over-thecounter medicines, vitamins, and herbal supplements. Especially tell your health care provider if you take medicine to control your heart beat (anti-arrhythmics) to control your blood pressure (such as beta-blockers or calcium channel blockers) to control potassium and magnesium (electrolytes) levels in your body that affects the electrical system in your heart (QT prolongation) cyclosporine bromocriptine Indication and Important Safety Information Signifor LAR (pasireotide) for injectable suspension INDICATION Signifor LAR is indicated for the treatment of patients with acromegaly for whom surgery has not worked well enough or who cannot have surgery. IMPORTANT SAFETY INFORMATION This information does not take the place of talking to your health care provider about your medical condition or your treatment. Signifor LAR may cause serious side effects described below. : Treatment with Signifor LAR may cause high blood sugar levels (hyperglycemia) and diabetes. Your health care provider should check your blood sugar level before you start receiving Signifor LAR and while you receive it. Tell your health care provider if you have any of these symptoms: excessive thirst urinate more than usual increased appetite with weight loss tiredness If you get hyperglycemia, your health care provider may give you medicine to lower your blood sugar. Your health care provider may also change your dose of Signifor LAR or ask you to stop receiving it. Treatment with Signifor LAR may cause your heart to beat slower (bradycardia) or cause changes in the electrical system of your heart (QT interval prolongation). Your health care provider should check your heart s electrical system with an ECG test prior to starting Signifor LAR and after 3 weeks in patients who may be at risk for electrical system problems. Call your health care provider right away if you experience any signs and symptoms such as: weakness fainting Treatment with Signifor LAR may cause elevations in liver function tests; therefore, your health care provider may do blood tests to monitor your liver. Treatment with Signifor LAR may affect your gallbladder (gallstones, cholelithiasis). Tell your health care provider right away if you experience any of the following signs and symptoms: sudden pain in the upper right stomach area (abdomen) Please see full Prescribing Information enclosed in pocket in back cover. sudden pain in the right shoulder or between your shoulder blades yellowing of the skin and whites of your eyes fever and chills nausea Treatment with Signifor LAR may affect your pituitary hormone levels (pituitary insufficiency). Signifor LAR may reduce the pituitary hormones in your body. Your health care provider should do a blood test to check your pituitary hormone levels before starting Signifor LAR and during treatment. Tell your health care provider if you experience any of these symptoms: nausea and vomiting tiredness diarrhea low blood glucose levels loss of appetite weight loss Common Side Effects: Most patients experience side effects at some time. Some common side effects you may experience include: diarrhea, gallstones, high blood sugar, and diabetes mellitus. Tell your health care provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of Signifor LAR. For more information and to get advice about side effects, ask your health care provider or pharmacist. Before taking Signifor LAR: Tell your health care provider about all the medicines you take including over-the-counter medicines, vitamins, and herbal supplements. Especially tell your health care provider if you take medicine to control your heart beat (anti-arrhythmics) to control your blood pressure (such as betablockers or calcium channel blockers) to control potassium and magnesium (electrolytes) levels in your body that affects the electrical system in your heart (QT prolongation) cyclosporine bromocriptine You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call FDA
7 Important things to remember 1 Keep Signifor LAR (pasireotide) for injectable suspension and all medicines out of the reach of children Store Signifor LAR in the refrigerator between 36 F to 46 F (2 C to 8 C) Signifor LAR can only be given to you by a trained health care professional Tell your doctor if you have any side effect that bothers you or that does not go away You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call FDA Reference: 1. Signifor LAR [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp; Novartis Pharmaceuticals Corporation East Hanover, New Jersey Novartis Printed in USA 6/15 SIA
TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT.
Keeping it Real. TIPS FOR GETTING THE MOST OUT OF YOUR TREATMENT. Guiding you through your treatment Taking KISQALI (ribociclib) as prescribed is essential to getting the most out of your treatment. That
More informationManaging Acromegaly: Review of Two Cases
Managing Acromegaly: Review of Two Cases INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of patients with acromegaly who have
More informationManaging Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide)
Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide) INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of
More informationA medicine to block the amount of acid produced in the stomach (H2 blocker): about 10 hours before about 2 hours after
TRACKING JOURNAL YOUR TRACKING JOURNAL Throughout your treatment with TASIGNA (nilotinib), your doctor will prescribe regular tests to see if your treatment is working. It s important to keep up with your
More informationGetting started with PROMACTA (eltrombopag)
Getting started with PROMACTA (eltrombopag) Indications PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to chronic immune (idiopathic)
More informationOpen to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level
If you have multiple myeloma and have already tried at least 2 other types of treatment Open to the possibility of a multiple myeloma treatment that works in cells in your body at the DNA level What is
More informationTreatment Journal. Therapy Tracker TREATMENT JOURNAL
TREATMENT JOURNAL Treatment Journal & Therapy Tracker Please see full Prescribing Information, including Boxed WARNING and Medication Guide, for FARYDAK (panobinostat) capsules. This journal can help you:
More informationTHE REAL DEAL ABOUT GETTING STARTED
THE REAL DEAL ABOUT GETTING STARTED Please see Important Safety Information throughout, and the Summary of Important Information on pages 44 47. Keeping it. INDICATIONS (ribociclib) is a prescription medicine
More informationTHE REAL DEAL ABOUT GETTING STARTED
THE REAL DEAL ABOUT GETTING STARTED Please see Important Safety Information throughout, and the Summary of Important Information on pages 34 37. Keeping it real. INDICATION (ribociclib) is a prescription
More informationYour guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer
Your guide to taking LENVIMA for hepatocellular carcinoma (HCC), a type of liver cancer LENVIMA is a prescription medicine that is used by itself as the first treatment for a type of liver cancer called
More informationOne daily pill can help prevent HIV. TRUVADA for PrEP, together with safer sex practices, can mean better protection.
TRUVADA for PrEP is a prescription medicine that can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices. TRUVADA for PrEP is only for people
More informationMedication Tracker for ZYTIGA (abiraterone acetate)
Medication Tracker for YTIGA (abiraterone acetate) See the next page to help set up a medication schedule that works for you, as directed by your doctor. Write in the administration times that suit you
More informationREADY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE
HELP GET READY FOR YOUR UPCOMING PROCEDURE READY. SET. DOPTELET. Full Prescribing Information for DOPTELET (avatrombopag), including Patient For adults with chronic liver disease and a low platelet count
More informationDiscussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor
Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor TECENTRIQ DISCUSSION SUPPORT What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: A type of bladder
More informationTips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects
Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects If you have been prescribed OFEV (nintedanib) capsules for the treatment of idiopathic pulmonary fibrosis (IPF) this brochure can help you
More informationTake CYCLOSET exactly as instructed by your health care provider, and be sure to read the Patient Information section of the package insert.
To help adults control type 2 diabetes along with diet and exercise UNLOCK YOUR INSULIN POTENTIAL A once-daily treatment that works in the brain to help you become more responsive to the insulin in your
More informationI. ALL CLAIMS: HEALTH CARE PROFESSIONALS
HCP Prescribing Information Date/Version January 2015 Version 2 Page: 1 of 5 I. ALL CLAIMS: HEALTH CARE PROFESSIONALS Indications and Usage Saxenda (liraglutide [rdna origin] injection) is indicated as
More informationStarting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet
For many adults with type 2 diabetes Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet Individual results may vary. Not actual patient. KAZANO is a prescription medicine
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET PROSTATIN (OCTREOTIDE ACETATE INJECTION 10mcg, 50mcg) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.
More informationMEDICATION GUIDE SUTENT
MEDICATION GUIDE SUTENT (su TENT) (sunitinib malate) capsules Read the Medication Guide that comes with SUTENT before you start taking it and each time you get a refill. There may be new information. This
More informationA GUIDE TO TREATMENT WHILE TAKING RYDAPT FOR ADVANCED SM
For patients with 3 types of systemic mastocytosis (SM)* * Aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL) are
More informationEMBRACING TODAY TOGETHER. A Guide For Caregivers
EMBRACING TODAY TOGETHER A Guide For Caregivers IBRANCE is a prescription medicine that is used along with the medicine letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive,
More information3 generations of ADPKD. 1 long-awaited treatment.
3 generations of ADPKD. 1 long-awaited treatment. HOPE is finally here now that treatment is available for people with autosomal dominant polycystic kidney disease (ADPKD). JYNARQUE is proven to slow kidney
More informationPatient s guide for switching to
Patient s guide for switching to ENVARSUS XR is taken just once a day. ENVARSUS XR is a tablet; it is the only tacrolimus product available in tablet form. All Day ENVARSUS XR is not substitutable with
More informationPATIENT INFORMATION. CRESEMBA (Crē sem bah) (isavuconazonium sulfate) Capsules, for oral administration
PATIENT INFORMATION CRESEMBA (Crē sem bah) (isavuconazonium sulfate) Capsules, for oral administration CRESEMBA (Crē sem bah) (isavuconazonium sulfate) For injection, for intravenous administration Read
More informationTake on IPF progression with OFEV
Every breath matters Take on IPF progression with OFEV Learn more at www.ofev.com IPF=idiopathic pulmonary fibrosis. Please see throughout Understand how IPF affects you Idiopathic pulmonary fibrosis (IPF)
More informationPatient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension
Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Read this Patient Information before you start taking VERSACLOZ and each time you get a refill. There may be new information. This
More informationAN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.
For estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer. AN ADVANCEMENT FOR POSTMENOPAUSAL WOMEN WITH ER+/HER2- METASTATIC BREAST CANCER.
More informationWhat should I ask my treatment team?
TREATMENT TRANSFORMED Child portrayed is not a real KYMRIAH patient. DISCUSSION GUIDE What should I ask my treatment team? Making treatment decisions for relapsed or refractory cancer can be hard. Asking
More informationYOUR CABOMETYX HANDBOOK
YOUR CABOMETYX HANDBOOK AN OVERVIEW FOR PATIENTS AND CAREGIVERS in the full Prescribing Information. Table of Contents What s included in this handbook... 3 A kidney cancer overview...4 About CABOMETYX...4
More informationRick N. EMPLICITI patient Ready to get started
Rick N. EMPLICITI patient Ready to get started PICTURE YOUR IMMUNE SYSTEM AT WORK AGAINST MULTIPLE MYELOMA Rick N. EMPLICITI patient My body taking on multiple myeloma What is EMPLICITI? EMPLICITI is a
More informationKEEP LOVING. Because HIV doesn t change who you are.
KEEP LOVING. Because HIV doesn t change who you are. BIKTARVY is a complete, 1-pill, once-a-day prescription medicine used to treat HIV-1 in certain adults. BIKTARVY does not cure HIV-1 or AIDS. Please
More informationONE PILL, ONCE A DAY GET TO KNOW AUBAGIO. Ask your doctor if AUBAGIO may be right for you. Patient Portrayal
ONE PILL, ONCE A DAY GET TO KNOW AUBAGIO Patient Portrayal Ask your doctor if AUBAGIO may be right for you. INDICATION AUBAGIO (teriflunomide) is a prescription medicine used to treat relapsing forms of
More informationCould your uncontrollable movements be tardive dyskinesia (TD)? There s a treatment with INGREZZA.
Lip smacking, eye blinking, dancing hands and fingers, hip jerking... Could your uncontrollable movements be tardive dyskinesia (TD)? There s a treatment with INGREZZA. Approved for adults with TD TD can
More informationTREATMENT PLAN WORKBOOK
TREATMENT PLAN WORKBOOK Keep track of everything related to your diagnosis and treatment Please see accompanying full Prescribing Information and Important Safety Information on page 15. Please see accompanying
More informationPATIENT INFORMATION. Metformin Hydrochloride Extended-Release Tablets USP (met-for-min HYE-droe-KLOR-ide)
PATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets USP (met-for-min HYE-droe-KLOR-ide) What is the most important information I should know about metformin hydrochloride extended-release
More informationGLEEVEC PATIENT RESOURCES
GLEEVEC TALKING WITH YOUR DOCTOR ABOUT KIT+ GIST AND ITS TREATMENT When you have KIT-positive gastrointestinal stromal tumor (KIT+ GIST), you will likely have many questions and may, at times, feel overwhelmed
More informationMEDICATION GUIDE. Quetiapine (kwe-tye-a-peen) Tablets USP
MEDICATION GUIDE Quetiapine (kwe-tye-a-peen) Tablets USP Read this Medication Guide before you start taking quetiapine tablets and each time you get a refill. There may be new information. This information
More informationPatient Information Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg Rx only
Patient Information Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg, 100 mg/12.5 mg and 100 mg/25 mg Rx only Read the Patient Information that comes with Losartan Potassium and Hydrochlorothiazide
More informationIf you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA
If you wake up to urinate 2 or more times a night, ask your doctor about NOCTIVA IMPORTANT SAFETY INFORMATION WARNING: HYPONATREMIA See full prescribing information for complete boxed warning. NOCTIVA
More informationTuscarawas County Health Department. Vivitrol Treatment Consent
Tuscarawas County Health Department Vivitrol Treatment Consent I. Vivitrol Medication Guide: a. VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) b. Read this Medication Guide
More informationYou are being asked to take octreotide as a treatment to manage the symptoms of your cancer.
For the Patient: UGIOTLAR Symptomatic management of functional carcinoid and neuroendocrine tumours of the GI tract using Octreotide (SANDOSTATIN LAR) UGI = Undesignated, GastroIntestinal OT = Octreotide
More informationNivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions
Nivolumab Other Names: Opdivo About this Drug Nivolumab is used to treat cancer. It is given in the vein (IV). Possible Side Effects (More Common) Bone marrow depression. This is a decrease in the number
More informationMEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use
MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use If you are taking PegIntron with REBETOL (ribavirin) with or without an approved hepatitis C virus (HCV)
More informationImportant Safety Information About TRUVADA to Reduce the Risk of Getting Human Immunodeficiency Virus 1 (HIV-1) Infection
Important Safety Information About TRUVADA to Reduce the Risk of Getting Human Immunodeficiency Virus 1 (HIV-1) Infection This booklet is for adults taking TRUVADA to reduce the risk of getting HIV-1 infection.
More informationFOR PATIENTS WITH SYMPTOMS OF SARCOIDOSIS. Treatment Journal. H.P. Acthar Gel is a prescription medication used to treat symptoms of sarcoidosis.
FOR PATIENTS WITH SYMPTOMS OF SARCOIDOSIS Treatment Journal H.P. Acthar Gel is a prescription medication used to treat symptoms of sarcoidosis. IMPORTANT SAFETY INFORMATION Who should NOT take Acthar?
More informationWhat are my treatment support resources?
What are my treatment support resources? Get help when you need it. Click here for full Prescribing Information including risk of SERIOUS SIDE EFFECTS and Medication Guide. We re here to help you......
More informationCould your uncontrollable movements be tardive dyskinesia (TD)?
Could your uncontrollable movements be tardive dyskinesia (TD)? For adults with TD, there's a convenient treatment with INGREZZA: One capsule, once daily. Important Information Approved Use INGREZZA (valbenazine)
More informationMEDICATION GUIDE XIGDUO XR (ZIG- DO- OH X- R) (dapagliflozin and metformin HCL extended-release) Tablets
XIGDUO XR (dapagliflozin and metformin HCl extended-release) tablets 5 MEDICATION GUIDE XIGDUO XR (ZIG- DO- OH X- R) (dapagliflozin and metformin HCL extended-release) Tablets What is the most important
More informationMEDICATION GUIDE Mefloquine Hydrochloride Tablets, USP
Important: Your doctor or pharmacist will give you an Information Wallet Card along with this Medication Guide. It has important information about mefloquine and should be carried with you at all times
More informationRandy J. EMPLICITI patient Ready to get started
Randy J. EMPLICITI patient Ready to get started PICTURE YOUR IMMUNE SYSTEM AT WORK AGAINST MULTIPLE MYELOMA Randy J. EMPLICITI patient My body taking on multiple myeloma What is EMPLICITI? EMPLICITI is
More information(sunitinib malate) for Kidney Cancer
Sutent (sunitinib malate) for Kidney Cancer Sutent is a medication used to treat adult patients with kidney cancer that has been surgically removed and at high risk of recurrence, or advanced kidney cancer
More informationYOUR GUIDE TO PATIENT SUPPORT SERVICES
YOUR GUIDE TO PATIENT SUPPORT SERVICES Please see Important Safety Information About ONIVYDE (irinotecan liposome injection) on pages 6 7. WHAT IS PROVYDE (ONIVYDE ACCESS SERVICES)? PROVYDE is a team of
More informationLearning More Can Make a Difference
When your advanced or metastatic HER2+ breast cancer progresses on an anthracycline, a taxane, and Herceptin (trastuzumab) T U R N T O T Y K E R B + C A P E C I T A B I N E Learning More Can Make a Difference
More informationSAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA.
FOR PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS SAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA. INDIVIDUAL RESULTS MAY VARY TREMFYA is a prescription medicine used to treat adults with moderate
More informationPeople who have received 1-3 prior treatments for their multiple myeloma may receive: Revlimid (lenalidomide)
FINDTHE THE FIND STRENGTH STRENGTH WITHIN WITHIN TOHELP HELPFIGHT FIGHT TO MULTIPLEMYELOMA MYELOMA MULTIPLE Rick N. N. patient Rick patient What is? is a prescription medicine used with other medications
More informationLearn more about. about tikosyn (dofetilide)
about tikosyn (dofetilide) Learn more about TIKOSYN (dofetilide) Always remember to talk with your doctor or pharmacist if you have questions. Information in this brochure cannot take the place of a talk
More informationDEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT
LET US HELP YOU FIND A CLEARER PATH FORWARD. DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT PERSONALIZED SUPPORT FREE MEDICATION* $0 CO-PAY* WELCOME KIT RECYCLABLE
More informationPATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets (met-for-min HYE-droe-KLOR-ide) Rx only
PATIENT INFORMATION Metformin Hydrochloride Extended-Release Tablets (met-for-min HYE-droe-KLOR-ide) Rx only What is the most important information I should know about metformin hydrochloride extended-release
More informationQuestions to ask your Doctor
Questions to ask your Doctor What is my current blood pressure? What are my target blood pressure numbers? What blood pressure medication(s) am I currently taking? How is this drug different from what
More informationGlaxoSmithKline Research Triangle Park, NC the ViiV Healthcare group of companies. All rights reserved. ZGN:XPI
by: GlaxoSmithKline 2015 the ViiV Healthcare group of companies. All rights reserved. ZGN:XPI MEDICATION GUIDE ZIAGEN (ZY-uh-jen) (abacavir) tablets ZIAGEN (ZY-uh-jen) (abacavir) oral solution What is
More informationARIKAYCE IMPORTANT SAFETY INFORMATION
ARIKAYCE The first and only FDA-approved medication for the treatment of refractory (difficult to treat) MAC lung disease as part of a combination antibacterial drug treatment plan MAC=Mycobacterium avium
More informationDiscussion guide. Questions to bring to your next doctor s appointment. Notes
Discussion guide Questions to bring to your next doctor s appointment As someone who has had a heart attack or has peripheral arterial disease (PAD), it s important to lower your chance of having a heart
More informationHave a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider
Have a healthy discussion Use this guide to start a conversation with your healthcare provider MAKE THE CONVERSATION COUNT Here are some things you may want to reflect on and discuss with your healthcare
More informationHow does my new treatment work?
How does my new treatment work? Get to know KEVZARA better. Click here for full Prescribing Information including 1 risk of SERIOUS SIDE EFFECTS and Medication Guide. You're starting KEVZARA... GOT A QUESTION?
More informationFor the Patient: USMAVNIV
For the Patient: USMAVNIV Other Names: Treatment of Unresectable or Metastatic Melanoma Using Nivolumab U = Undesignated (requires special approval) SM = Skin and Melanoma AV = AdVanced NIV = NIVolumab
More informationPatient Information MICARDIS HCT (my-car-dis HCT) (telmisartan and hydrochlorothiazide) Tablets
Patient Information MICARDIS HCT (my-car-dis HCT) (telmisartan and hydrochlorothiazide) Tablets Read this Patient Information before you start taking MICARDIS HCT tablets and each time you get a refill.
More informationPatient Information. Telmisartan and Hydrochlorothiazide (TEL-mi-SAR-tan and HYE-droe-KLOR-oh-THYE-a-zide) Tablets. Rx Only
Patient Information Telmisartan and Hydrochlorothiazide (TEL-mi-SAR-tan and HYE-droe-KLOR-oh-THYE-a-zide) Tablets Rx Only Read this Patient Information before you start taking telmisartan and hydrochlorothiazide
More informationsevere diarrhea? Do you have ZINPLAVA is a medicine that helps reduce the risk that your C diff will come back.
Do you have severe diarrhea? It could be a potentially serious infection known as C diff, caused by the bacteria Clostridium difficile. In some people, C diff can come back. Not an actual patient. ZINPLAVA
More informationWE RE IN A CONSTANT STRUGGLE. BUT WITH AFINITOR, WE VE FOUND ANOTHER OPTION.
SEGA TSC Novartis Pharmaceuticals Corporation is committed to supporting individuals affected by SEGA with TSC through therapeutic innovation, patient assistance, and support of advocacy organizations.
More informationFor the Patient: ULUAVPMB
For the Patient: ULUAVPMB Other Names: Treatment of Advanced Non-Small Cell Lung Cancer Using Pembrolizumab U = Undesignated (requires special approval) LU = LUng AV = AdVanced PMB = PeMBrolizumab ABOUT
More informationMedication Guide SEGLUROMET (seg-lur-oh-met) (ertugliflozin and metformin hydrochloride) tablets, for oral use
Medication Guide SEGLUROMET (seg-lur-oh-met) (ertugliflozin and metformin hydrochloride) tablets, for oral use Read this Medication Guide carefully before you start taking SEGLUROMET and each time you
More informationSUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION
SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place
More informationTAFINLAR + MEKINIST. for more moments FOR PATIENTS WITH A CERTAIN TYPE OF BRAF+ ADVANCED MELANOMA
Treatment guide for patients and caregivers FOR PATIENTS WITH A CERTAIN TYPE OF BRAF+ ADVANCED MELANOMA TAFINLAR + MEKINIST A treatment option specifically made for your type of melanoma for more moments
More informationActhar TREATMENT JOURNAL
Acthar TREATMENT JOURNAL Help for patients in the grip of dermatomyositis or polymyositis What is Acthar? Acthar is a prescription medicine used for flares or on a regular basis (maintenance) in people
More informationDISCOVER INVEGA TRINZA
DISCOVER INVEGA TRINZA THE ONLY SCHIZOPHRENIA TREATMENT TO CONTROL SYMPTOMS FOR THREE MONTHS WITH ONE DOSE.* * After being adequately treated with INVEGA SUSTENNA (paliperidone palmitate), the once-monthly
More informationA GUIDE TO STARTING TREATMENT
A GUIDE TO STARTING TREATMENT Please see accompanying and Medication Guide. full Prescribing IDHIFA (enasidenib) is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an
More informationMEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:
MEDICATION GUIDE Lamotrigine (lam-oh-try-jeen) Tablets USP Rx only What is the most important information I should know about lamotrigine tablets? 1. Lamotrigine tablets may cause a serious skin rash that
More informationYou matter and so does your health.
DESCOVY is a prescription medicine that is used together with other HIV-1 medicines to treat HIV-1 in people who weigh at least 77 lbs (35kg). DESCOVY does not cure HIV-1 or AIDS. Do not use DESCOVY to
More informationPage 1 of 5 VERZENIO abemaciclib tablet Eli Lilly and Company AddendaIndex Summary View All Sections HIGHLIGHTS OF PRESCRIBING INFORMATION FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE
More informationGetting started on MYALEPT (metreleptin) for injection
For problems of leptin deficiency in people with congenital or acquired generalized lipodystrophy Getting started on MYALEPT (metreleptin) for injection MEET LORELEI, A YOUNG GIRL WITH ACQUIRED GENERALIZED
More informationMEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use
MEDICATION GUIDE BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use Read this Medication Guide before you start receiving BENLYSTA and before each treatment. There may be new information.
More informationINVOKAMET (canagliflozin and metformin hydrochloride) tablets
Medication Guide INVOKAMET (in vok a met) (canagliflozin and metformin hydrochloride) Tablets What is the most important information I should know about INVOKAMET? INVOKAMET can cause serious side effects,
More informationPatient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol. Do not use your ALVESCO Inhalation Aerosol near heat or an open flame.
Note: For Oral Inhalation Only Patient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol Do not use your ALVESCO Inhalation Aerosol near heat or an open flame. Read this Patient Information
More informationWhat You Need to Know About ARZERRA (ofatumumab)
Starting your treatment for chronic lymphocytic leukemia (CLL) What You Need to Know About ARZERRA (ofatumumab) Approved Use ARZERRA is a prescription medication used: With a chemotherapy drug called chlorambucil
More informationWhat is the most important information I should know about carbamazepine tablets or chewable tablets?
MEDICATION GUIDE Carbamazepine (kar ba MAZ e peen) Tablets, USP, 100 mg, 200 mg, 300 mg, 400 mg and Carbamazepine (kar ba MAZ e peen) Tablets, USP (Chewable), 100 mg Rx Only Read this Medication Guide
More informationPatient Information Entecavir Tablets (en-tek-ah-veer)
Patient Information Entecavir Tablets (en-tek-ah-veer) Read this Patient Information before you start taking entecavir tablets and each time you get a refill. There may be new information. This information
More informationMEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)
MEDICATION GUIDE Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP) Read this Medication Guide before you start taking PEGANONE and each time you get a refill. There may be new information.
More informationA GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX
A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX You are encouraged to have an open conversation with your doctor about your treatment goals and current medicines. It is important in determining if
More informationPatient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA?
17.6 FDA-Approved Patient Labeling Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) for Injection, for intravenous infusion only Read the Patient Information that comes with IXEMPRA
More informationDiscover CRYSVITA and Redefine XLH TREATMENT
Discover CRYSVITA and Redefine XLH TREATMENT CRYSVITA is a prescription medicine used to treat adults and children 1 year of age and older with X-linked hypophosphatemia (XLH). 10 mg/ml, 20 mg/ml, 30 mg/ml
More informationPatient Information VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder
Patient Information VIREAD (VEER-ee-ad) (tenofovir disoproxil fumarate) tablets and oral powder Read this Patient Information before you start taking VIREAD and each time you get a refill. There may be
More informationCapecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions
Capecitabine Other Names: Xeloda About This Drug Capecitabine is used to treat cancer. It is given orally (by mouth). Possible Side Effects Tired and weakness Loose bowel movements (diarrhea) Nausea and
More informationALECENSA (alectinib) Fact Sheet
ALECENSA (alectinib) Fact Sheet What is NSCLC? ALECENSA is a kinase inhibitor approved for the treatment of people with anaplastic lymphoma kinase (ALK)-positive, metastatic non-small cell lung cancer
More informationLIVING PROOF. 23% Reduction in the risk of death compared with standardof-care. A guide to combination treatment with RYDAPT
My LIVING PROOF THAT TREATING NEWLY DIAGNOSED FLT3-POSITIVE AML HAS CHANGED 23% Reduction in the risk of death compared with standardof-care chemotherapy alone A specific median overall survival (the time
More informationA Guide for Patients and Caregivers
DLBCL Starting KYMRIAH A Guide for Patients and Caregivers APPROVED USE WHAT IS KYMRIAH? KYMRIAH (tisagenlecleucel) is made from your own white blood cells and is a prescription cancer treatment used in
More informationFDA APPROVED MEDICATION GUIDE
FDA APPROVED MEDICATION GUIDE Valproic Acid Oral Solution Read this Medication Guide before you start taking valproic acid and each time you get a refill. There may be new information. This information
More informationNovartis announces update to United States prescribing information for MS therapy Gilenya following FDA review
Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJ 07936-1080 www.pharma.us.novartis.com MEDIA RELEASE MEDIA RELEASE MEDIA RELEASE Novartis announces update to United States prescribing
More information